Report Overview:
Implantable cardiac monitors (ICM) are small electrophysiology (EP) devices that used for long-term monitoring of a patient's heart electrical activity to detect arrhythmias. The technology can eliminate the need for a bulkly external Holter monitor that requires wire leads attached to the patient. ICMs can be inserted under the skin during and office visit and record cardiac data continuously for up to 4.5 years.
This report provides a deep insight into the global Insertable Heart Monitors market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
Market Value:
The global Insertable Heart Monitors market size was estimated at USD 502 million in 2024 and is projected to reach USD 938.55 million by 2032, exhibiting a CAGR of 7.20% during the forecast period.
By Types:
• Implantation Loop Recorder (ILR)
• Insertable Cardiac Monitor (ICM)
By Applications: Medical
Household
Key players include:
• Medtronic
• Abbott
• Boston Scientific Corporation
• BIOTRONIK
• Vectorious
• LivaNova
• Including or Excluding key companies relevant to your analysis.
